Nitric oxide inhibits the formation of advanced glycation end products.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Kidney International

• Publication date

  2000-10-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1111/J.1523-1755.2000.00340.XPMID 11012913
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nitric oxide production is low in end-stage renal disease patients on peritoneal dialysis.

  1999cited by this paper
• Nitric oxide production is reduced in patients with chronic renal failure.

  1999cited by this paper
• Alterations in nonenzymatic biochemistry in uremia: origin and significance of "carbonyl stress" in long-term uremic complications.

  1999cited by this paper
• 2‐Isopropylidenehydrazono‐4‐oxo‐thiazolidin‐5‐ylacetanilide (OPB‐9195) treatment inhibits the development of intimal thickening after balloon injury of rat carotid artery: role of glycoxidation and lipoxidation reactions in vascular tissue damage

  1999cited by this paper
• Generation of protein carbonyls by glycoxidation and lipoxidation reactions with autoxidation products of ascorbic acid and polyunsaturated fatty acids

  1998cited by this paper
• Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis.

  1998cited by this paper
• Implication of altered redox regulation by antioxidant enzymes in the increased plasma pentosidine, an advanced glycation end product, in uremia.

  1998cited by this paper
• Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis.

  1998cited by this paper
• Accumulation of carbonyls accelerates the formation of pentosidine, an advanced glycation end product: carbonyl stress in uremia.

  1998cited by this paper
• Advanced glycation end products increase retinal vascular endothelial growth factor expression.

  1998cited by this paper
• Increased aggregation of human platelets produced by advanced glycation end products in vitro.

  1998cited by this paper
• Autoxidation products of both carbohydrates and lipids are increased in uremic plasma: is there oxidative stress in uremia?

  1998cited by this paper
• Constitutive nitric oxide synthase expression in retinal vascular endothelial cells is suppressed by high glucose and advanced glycation end products.

  1998cited by this paper
• Oxidation conspires with glycation to generate noxious advanced glycation end products in renal failure.

  1997cited by this paper
• Advanced glycation endproducts stimulate mitogen-activated protein kinase and proliferation in rabbit vascular smooth muscle cells.

  1997cited by this paper
• Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure.

  1997cited by this paper
• Physiology and biochemistry of endothelial function in children with chronic renal failure.

  1997cited by this paper
• The formation of some antigenic epitopes in oxidized human low-density lipoprotein is inhibited by nitric oxide.

  1997cited by this paper
• Identification of pentosidine as a native structure for advanced glycation end products in beta-2-microglobulin-containing amyloid fibrils in patients with dialysis-related amyloidosis.

  1996cited by this paper
• Nitric oxide released from zwitterionic polyamine/NO adducts inhibits Cu2+‐induced low density lipoprotein oxidation

  1996cited by this paper
• Accumulation of albumin-linked and free-form pentosidine in the circulation of uremic patients with end-stage renal failure: renal implications in the pathophysiology of pentosidine.

  1996cited by this paper
• Mechanism of autoxidative glycosylation: identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose.

  1995cited by this paper
• Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleukin-1.

  1994cited by this paper
• Antagonistic action of imidazolineoxyl N-oxides against endothelium-derived relaxing factor/.NO through a radical reaction.

  1993cited by this paper
• Inhibition of low‐density lipoprotein oxidation by nitric oxide Potential role in atherogenesis

  1993cited by this paper
• Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure.

  1992cited by this paper
• Chromatographic Quantitation of Plasma and Erythrocyte Pentosidine in Diabetic and Uremic Subjects

  1992cited by this paper
• Advanced glycosylation end products in patients with diabetic nephropathy.

  1991cited by this paper
• The detection of halocarbon-derived radical adducts in bile and liver of rats.

  1991cited by this paper
• Formation of pentosidine during nonenzymatic browning of proteins by glucose. Identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo.

  1991cited by this paper
• Mechanism of formation of the Maillard protein cross-link pentosidine. Glucose, fructose, and ascorbate as pentosidine precursors.

  1991cited by this paper
• Role of Oxidative Stress in Development of Complications in Diabetes

  1991cited by this paper
• Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging.

  1990cited by this paper
• Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling.

  1988cited by this paper
• Hydroxyl radical production and autoxidative glycosylation. Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing.

  1988cited by this paper
• An unusually stable thionitrite from N-acetyl-D,L-penicillamine; X-ray crystal and molecular structure of 2-(acetylamino)-2-carboxy-1,1-dimethylethyl thionitrite

  1978cited by this paper
• The use of Girard-T reagent in a rapid and sensitive methods for measuring glyoxal and certain other alpha-dicarbonyl compounds.

  1977cited by this paper

• Statins and non-alcoholic fatty liver disease: A concise review.

  2025cites this paper
• Nε-(carboxymethyl)lysine-modified albumin exacerbates doxorubicin-induced NOX5-dependent oxidative stress in endothelial cells.

  2025cites this paper
• Influence of Nitrosyl Iron Complex with Thiosulfate Ligands on Therapeutically Important Targets Related to Type 2 Diabetes Mellitus

  2023cites this paper
• Nitric Oxide-Scavenging, Anti-Migration Effects, and Glycosylation Changes after Hemin Treatment of Human Triple-Negative Breast Cancer Cells: A Mechanistic Study

  2023cites this paper
• Role of Nitric Oxide-Derived Metabolites in Reactions of Methylglyoxal with Lysine and Lysine-Rich Protein Leghemoglobin

  2022influential citation
• DIAGNOSTIC APPROACHES AND FORECASTING IN THE INTENSIVE CARE

  2022cites this paper
• The Influence of Nitroxyl on Escherichia coli Cells Grown under Carbonyl Stress Conditions

  2022cites this paper
• Antiglycation and Antioxidant Effect of Nitroxyl towards Hemoglobin

  2022cites this paper
• The Role of Protein Adduction in Toxic Neuropathies of Exogenous and Endogenous Origin

  2021cites this paper
• Current trends in management of hyperglycaemia in surgical patients with diabetes mellitus: a review

  2021cites this paper
• Endothelial Dysfunction: A Contributor to Adverse Cardiovascular Remodeling and Heart Failure Development in Type 2 Diabetes beyond Accelerated Atherogenesis

  2020cites this paper
• Exploring the role of body mass index in relationship of serum nitric oxide and advanced glycation end products in apparently healthy subjects

  2019cites this paper
• КАРДИОМИОЦИТЫ КЛЕТКИ ВОРОТНОЙ ВЕНЫ КРЫС С ХРОНИЧЕСКОЙ ПОЧЕЧНОЙ НЕДОСТАТОЧНОСТЬЮ SPECIFIC EFFECTS OF LOW INTENSITY LASER IRRADIATION (632.6 NM) ON CARDIOMYOCYTES AND SMOOTH MUSCLE CELLS OF THE PORTAL VEIN OF RATS WITH CHRONIC RENAL FAILURE

  2018cites this paper
• Role of Advanced Glycation End Products in the Progression of Diabetes Mellitus

  2017cites this paper
• Marked increase in rat red blood cell membrane protein glycosylation by one-month treatment with a cafeteria diet

  2015cites this paper
• Formation of nitri- and nitrosylhemoglobin in systems modeling the Maillard reaction

  2014cites this paper
• Changes of serum parameters of TiO₂ nanoparticle-induced atherosclerosis in mice.

  2014cites this paper
• Carbonyl Stress in Uremia

  2013cites this paper
• The AGEeRAGE Pathway and Its Relation to Cardiovascular Disease in Patients with Chronic Kidney Disease

  2013cites this paper
• EFFECT OF NATURAL COCOA POWDER SUPPLEMENTATION ON OXIDATIVE STRESS AND HEMATOLOGICAL INDICES IN HEALTHY GHANAIAN ADULTS

  2013cites this paper
• The AGE-RAGE pathway and its relation to cardiovascular disease in patients with chronic kidney disease.

  2013cites this paper
• Advanced Glycation End Products: A Review

  2013cites this paper
• Novel mechanistic insights into the role of advanced glycation end products in the development of diabetic cardiomyopathy

  2012cites this paper
• Platelet adhesion in atherogenesis

  2010cites this paper
• Renoprotection, renin inhibition, and blood pressure control: the impact of aliskiren on integrated blood pressure control

  2010cites this paper
• RAGE (Receptor for Advanced Glycation Endproducts), RAGE Ligands, and their role in Cancer and Inflammation

  2009cites this paper
• Uremic and Dialysis Encephalopathies

  2009cites this paper
• RAGE mediates podocyte injury in adriamycin-induced glomerulosclerosis.

  2008cites this paper
• Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/- mice.

  2008cites this paper
• Comparative effects of N-acetyl-L-cysteine and ramipril on arterial hypertension, insulin resistance, and oxidative stress in chronically glucose-fed rats.

  2008cites this paper
• Advanced Glycation and ROS: a link between diabetes and heart failure.

  2008cites this paper
• Oxidatively-modified and glycated proteins as candidate pro-inflammatory toxins in uremia and dialysis patients

  2007cites this paper
• Injury Advanced Glycation End Products : Sparking the Development of Diabetic Vascular

  2006cites this paper
• Chronic Renal Disease : Orthomolecular Ramifications

  2006cites this paper
• Advanced glycation end products: sparking the development of diabetic vascular injury.

  2006cites this paper
• Suppression of nNOS expression in rat enteric neurones by the receptor for advanced glycation end‐products

  2006cites this paper
• Analysis and biological properties of amino acid derivates formed by Maillard reaction in foods.

  2006cites this paper
• Putative roles of kinin receptors in the therapeutic effects of angiotensin 1-converting enzyme inhibitors in diabetes mellitus.

  2004cites this paper
• Possible pathologic involvement of receptor for advanced glycation end products (RAGE) for development of encapsulating peritoneal sclerosis in Japanese CAPD patients.

  2004cites this paper
• Paradox of circulating advanced glycation end product concentrations in patients with congestive heart failure and after heart transplantation

  2004cites this paper
• Vascular protective actions of a nitric oxide aspirin analog in both in vitro and in vivo models of diabetes mellitus.

  2002cites this paper
• Toward better dialysis compatibility: advances in the biochemistry and pathophysiology of the peritoneal membranes.

  2002cites this paper
• Hyperglycemic switch from mitochondrial nitric oxide to superoxide production in endothelial cells.

  2002cites this paper
• Transformed cell-derived reactive oxygen species support and inhibit nitric oxide-mediated apoptosis induction.

  2002cites this paper
• A Personal Nanomedical Appliance to Replace Human Blood

  2002cites this paper
• Angiotensin II receptor antagonists and angiotensin-converting enzyme inhibitors lower in vitro the formation of advanced glycation end products: biochemical mechanisms.

  2002cites this paper
• Pathophysiology of hypertension and endothelial dysfunction in patients with diabetes mellitus.

  2001cites this paper
• Reactive carbonyl compounds as uremic toxins.

  2001cites this paper
• A Food Chemist'S View of Advanced Glycation End-Products

  2001cites this paper
• Advanced glycation end products and the progressive course of renal disease.

  2001cites this paper
• Uremic Toxicity: Present State of the Art

  2001cites this paper
• Nitric oxide, advanced glycation end products, and uremia.

  2000cites this paper